MDS Pharma Services (NYSE:MDZ) (TSX:MDS), a leading provider of innovative drug discovery and development solutions, will host a free pharmaceutics-focused Scientific Leadership Series seminar on "Increasing the Value of Your Small Molecule through Expedited Strategies Leading to First-in-Man Oral Dosing," in La Jolla, California, on June 16, 2005. Industry experts will address early phase development challenges associated with achieving speed to first-in-man studies.

Scientific sessions will focus on strategies for expedited formulation, precision powder microdosing, and managing risk. Topics and speakers for the event will include:

An additional interactive session will feature a discussion of early stage financing strategies moderated by MDS Capital Corp. with a panel of several local firms focused on funding and capital formation.

"We know that reducing the time to first-in-man studies increases the value of small molecules," said Derek Hennecke, MDS Pharma Services vice president and general manager, Pharmaceutics and Biopharmaceuticals. "This seminar is a great opportunity to delve deeper into the challenges of expedited drug formulation, sub-therapeutic dosing and early stage financing."

Individuals interested in attending this free Scientific Leadership Series seminar are encouraged to register online at www.mdsps.com/events/SanDiego2005.htm, or via e-mail at pharmaceutics.symposium@mdsps.com.

MDS Pharma Services offers a full spectrum of resources to meet the drug discovery and development needs of the pharmaceutical and biotechnology industries. With numerous facilities strategically located around the world, the company applies advanced scientific and technological expertise to each stage of the drug discovery and development process - early stage: lead optimization, pre-IND research, pharmaceutical and biopharmaceutical development, early clinical research (bioequivalence, phases I-IIa) and bioanalysis; and late stage: global clinical development (phases IIb-IV) and central lab. For more information, visit MDS Pharma Services' Web site at www.mdsps.com.

MDS Pharma Services is an integral part of MDS Inc. (NYSE:MDZ) (TSX:MDS). MDS Inc. has more than 9,000 highly skilled people in 25 countries. We provide a diverse range of superior products and services to increase our customers' speed, precision and productivity in the drug development and disease diagnosis processes. We are a global, values-driven health and life sciences company, recognized for our reliability and collaborative relationships as we help create better outcomes in the treatment of disease. Find out more at www.mdsintl.com or by calling 1-888-MDS-7222, 24 hours a day.